|
Condensed Consolidated Statements Of Operations (USD $)
|
12 Months Ended |
|
Dec. 31, 2014
|
Dec. 31, 2013
|
| Statements of Operations [Abstract] |
|
|
| Revenues |
|
|
| Costs of goods sold |
|
|
| Gross Profit |
|
|
| Operating Expenses |
|
|
| General and administrative |
2,432,660 |
835,162 |
| Selling and marketing |
1,396,077 |
81,323 |
| Research and development |
1,417,745 |
518,614 |
| Total Operating Expenses |
5,246,482 |
1,435,099 |
| Operating Loss |
(5,246,482) |
(1,435,099) |
| Other Income and (Expense) |
|
|
| Interest income |
1,235 |
|
| Interest expense |
(30,744) |
(35,461) |
| Inducement expense |
(2,212,538) |
|
| Unrealized gain (loss) on change in fair value of derivative liabilities |
412,763 |
(73,974) |
| Total Other Expense, Net |
(1,829,284) |
(109,435) |
| Loss before Income Taxes |
(7,075,766) |
(1,544,534) |
| Provision for Income Taxes |
(843) |
|
| Net Loss |
$ (7,076,609) |
$ (1,544,534) |
| Net Loss Per Share - Basic and Diluted |
$ (0.31) |
$ (0.07) |
| Weighted Average Number of Common Shares Outstanding - Basic and Diluted |
22,849,010 |
21,409,369 |